Beta-Lactam Selection in Community-Acquired Pneumonia
A medical student is presenting on a patient with community-acquired pneumonia.
The team agrees they want to treat with a beta-lactam + macrolide. Which beta-lactam recommended per the 2019 ATS/IDSA guidelines is LOWEST risk for Clostridioides difficile?
A. Ampicillin/sulbactam
B. Cefotaxime
C. Ceftriaxone
D. Ceftaroline
How did others respond?
